<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03388476</url>
  </required_header>
  <id_info>
    <org_study_id>AZ 156/17</org_study_id>
    <secondary_id>DRKS00013589</secondary_id>
    <secondary_id>AZ 156/17</secondary_id>
    <nct_id>NCT03388476</nct_id>
  </id_info>
  <brief_title>Endtidal Carbon Dioxide for Earlier Detection of Pulmonary Hypertension</brief_title>
  <acronym>EARLIER</acronym>
  <official_title>Endtidal Carbon Dioxide for Earlier Detection of Pulmonary Hypertension in Patients With Suspicion of Pulmonary Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Giessen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Giessen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Measurement of the endtidal carbon dioxide by capnography to exclude or to ensure the
      diagnosis pulmonary hypertension. The aim of the study is to obtain an endtidal carbon
      dioxide cut-off value for the diagnostic algorithm for pulmonary hypertension as an easily
      measurable and cheap diagnostic tool in patients with suspicion of pulmonary hypertension.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The disease pulmonary hypertension is due to a remodeling of the lung vessels which results
      in a change of the exhaled air. This change is measurable with a so called capnograph. The
      investigators want to measure the breath from patients with and without pulmonary
      hypertension to detect a cut-off value for the diagnosis pulmonary hypertension.

      Patients which have the probably diagnosis pulmonary hypertension and are older than 18 years
      are investigated. This patients will get an right heart catheterization and a measurement
      from their exhaled air.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 2, 2018</start_date>
  <completion_date type="Anticipated">January 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement PetCO2</measure>
    <time_frame>At baseline</time_frame>
    <description>Measurement PetCO2 by capnography at rest after or before a right heart catheterization, comparison of the parameter between patients with and without</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Establishing a cut-off</measure>
    <time_frame>At baseline</time_frame>
    <description>Establishing a cut-off for the non-invasive diagnosing of pulmonary hypertension, which differs between patients with and without pulmonary hypertension and save patients without the disease before a dispensable invasive right heart catheterization</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Hypertension, Pulmonary</condition>
  <condition>Hypertension;Pulmonary;Primary</condition>
  <condition>Chronic Thromboembolic Pulmonary Hypertension</condition>
  <condition>Vascular Diseases</condition>
  <condition>Lung Diseases</condition>
  <arm_group>
    <arm_group_label>Suspicion of pulmonary hypertension</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>At Patients with suspicion of pulmonary hypertension, which get a right heart catheterization, in the context of the study the exhaled air, precious the endtidal carbon dioxide (CO2), before or after the right heart catheterization will be measured through capnography.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Capnography</intervention_name>
    <description>Measuring of the exhaled air, especially endtidal co2, through capnography.</description>
    <arm_group_label>Suspicion of pulmonary hypertension</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Age &gt; 18 years, suspicion of pulmonary hypertension, planned or accomplished right heart
        catheterization

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Henning Gall, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Clinic Giessen and Marburg - Campus Giessen, Department of Internal Medicine II, Division of Pulmonology, Nephrology and Critical Care Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Werner Seeger, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>University Clinic Giessen and Marburg - Campus Giessen, Department of Internal Medicine II, Division of Pulmonology, Nephrology and Critical Care Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ardeschir Ghofrani, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>University Clinic Giessen and Marburg - Campus Giessen, Department of Internal Medicine II, Division of Pulmonology, Nephrology and Critical Care Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Clinic Giessen and Marburg</name>
      <address>
        <city>Giessen</city>
        <state>Hessen</state>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Hemnes AR, Pugh ME, Newman AL, Robbins IM, Tolle J, Austin ED, Newman JH. End tidal CO(2) tension: pulmonary arterial hypertension vs pulmonary venous hypertension and response to treatment. Chest. 2011 Nov;140(5):1267-1273. doi: 10.1378/chest.11-0155. Epub 2011 May 26.</citation>
    <PMID>21622547</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 22, 2017</study_first_submitted>
  <study_first_submitted_qc>December 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">January 3, 2018</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Giessen</investigator_affiliation>
    <investigator_full_name>Sophie Herbst</investigator_full_name>
    <investigator_title>Study Chair: Ghofrani H. Ardeschir, Prof. Dr. University of Giessen</investigator_title>
  </responsible_party>
  <keyword>pulmonary hypertension</keyword>
  <keyword>endtidal co2</keyword>
  <keyword>endtidal carbon dioxide</keyword>
  <keyword>pulmonary arterial hypertension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

